Marshall Wace North America’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,248
| Closed | -$579K | – | 1556 |
|
|
2021
Q2 | $579K | Buy |
+2,248
| New | +$579K | ﹤0.01% | 1091 |
|
|
2019
Q2 | – | Sell |
-3,949
| Closed | -$1.99M | – | 1456 |
|
|
2019
Q1 | $1.99M | Sell |
3,949
-3,161
| -44% | -$1.59M | 0.01% | 512 |
|
|
2018
Q4 | $3.51M | Buy |
+7,110
| New | +$3.51M | 0.03% | 320 |
|
|
2018
Q2 | – | Sell |
-25,181
| Closed | -$40.1M | – | 1585 |
|
|
2018
Q1 | $40.1M | Buy |
25,181
+19,769
| +365% | +$31.5M | 0.2% | 119 |
|
|
2017
Q4 | $4.85M | Buy |
+5,412
| New | +$4.85M | 0.03% | 588 |
|
|
2017
Q3 | – | Sell |
-14,170
| Closed | -$4.25M | – | 1430 |
|
|
2017
Q2 | $4.25M | Sell |
14,170
-54,178
| -79% | -$16.3M | 0.03% | 543 |
|
|
2017
Q1 | $23.6M | Buy |
+68,348
| New | +$23.6M | 0.19% | 149 |
|